CPRX FCF Yield: current value, 10-year range and year-by-year history
Cash & Leverage
CPRX's fcf yield is right around its 10-year median of 6.0%.
FCF Yield History
CPRX FCF Yield by year
Yearly range of CPRX’s fcf yield from 2016 to 2026. Over the full period it ranged from -23.0% to 14.9%, averaging 2.3%.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 5.2% | 6.1% | 7.3% | 5.2% |
| 2025 | 7.0% | 9.1% | 11.3% | 7.0% |
| 2024 | -1.4% | 6.1% | 10.3% | 9.1% |
| 2023 | -3.3% | -0.4% | 7.1% | -1.9% |
| 2022 | 4.4% | 6.9% | 10.3% | 4.6% |
| 2021 | 6.3% | 8.3% | 12.3% | 8.1% |
| 2020 | 6.2% | 10.8% | 14.9% | 12.7% |
| 2019 | -11.9% | -3.5% | 8.7% | 8.7% |
| 2018 | -13.1% | -5.7% | -3.8% | -13.1% |
| 2017 | -20.0% | -9.7% | -3.8% | -4.3% |
| 2016 | -23.0% | -20.1% | -18.1% | -21.0% |
Free cash flow generated divided by market capitalisation. Often more reliable than earnings yield because it reflects actual cash — harder to inflate through accounting choices.
Free Cash Flow / Market Cap × 100%Think of it as the "cash earnings yield" on your investment. High FCF yield vs history suggests the market may be undervaluing the company's real cash generation ability.
- FCF can be lumpy year-to-year due to irregular capex or working capital swings. Look at 3–5 year trends, not single-year readings.
- Businesses intentionally reinvesting for growth will show low or negative FCF yield by design — this metric is less useful for high-growth phase companies.
Is CPRX FCF Yield High or Low Right Now?
Catalyst Pharmaceuticals, Inc.'s FCF Yield is currently 5.2%, which is around average relative to its 10-year historical range. The 10-year median FCF Yield for CPRX is approximately 6.0%. See all CPRX valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.